Company intelligence / Profile preview

Struthio BioSciences

Kyoto, Kyoto, Japan

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Struthio BioSciences is a biotechnology company specializing in the development and production of ostrich-derived antibodies (IgY). Leveraging the unique immune system of ostriches, the company produces antibodies that are highly heat-resistant, stable, and cost-effective compared to traditional mammalian antibodies. Their technology is applied across various sectors, including functional skincare, protective equipment like virus-blocking masks, and the development of therapeutic candidates for infectious diseases. Struthio BioSciences aims to provide scalable antibody solutions for global health challenges and consumer wellness.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: AntibodyOstrich IgY antibody
Industry: Biotech

Partnerships

Kyoto Prefectural UniversityOstrich Pharma

Beyond the preview

Go deeper on Struthio BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Struthio BioSciences.

Explore the full profile